Literature DB >> 26176812

MoFvAb: Modeling the Fv region of antibodies.

Alexander Bujotzek1, Angelika Fuchs, Changtao Qu, Jörg Benz, Stefan Klostermann, Iris Antes, Guy Georges.   

Abstract

Knowledge of the 3-dimensional structure of the antigen-binding region of antibodies enables numerous useful applications regarding the design and development of antibody-based drugs. We present a knowledge-based antibody structure prediction methodology that incorporates concepts that have arisen from an applied antibody engineering environment. The protocol exploits the rich and continuously growing supply of experimentally derived antibody structures available to predict CDR loop conformations and the packing of heavy and light chain quickly and without user intervention. The homology models are refined by a novel antibody-specific approach to adapt and rearrange sidechains based on their chemical environment. The method achieves very competitive all-atom root mean square deviation values in the order of 1.5 Å on different evaluation datasets consisting of both known and previously unpublished antibody crystal structures.

Entities:  

Keywords:  AMA, Antibody Modeling Assessment; RMSD, root mean square deviation; amino acid sidechain conformation; antibody structure; homology modeling; macromolecular modeling; protein domain orientation; protein engineering; protein structure prediction

Mesh:

Substances:

Year:  2015        PMID: 26176812      PMCID: PMC4622929          DOI: 10.1080/19420862.2015.1068492

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  61 in total

1.  ABangle: characterising the VH-VL orientation in antibodies.

Authors:  J Dunbar; A Fuchs; J Shi; C M Deane
Journal:  Protein Eng Des Sel       Date:  2013-05-24       Impact factor: 1.650

2.  Developability index: a rapid in silico tool for the screening of antibody aggregation propensity.

Authors:  Timothy M Lauer; Neeraj J Agrawal; Naresh Chennamsetty; Kamal Egodage; Bernhard Helk; Bernhardt L Trout
Journal:  J Pharm Sci       Date:  2011-09-20       Impact factor: 3.534

3.  Antibody modeling assessment.

Authors:  Juan C Almagro; Mary Pat Beavers; Francisco Hernandez-Guzman; Johannes Maier; Jodi Shaulsky; Kenneth Butenhof; Paul Labute; Nels Thorsteinson; Kenneth Kelly; Alexey Teplyakov; Jinquan Luo; Raymond Sweet; Gary L Gilliland
Journal:  Proteins       Date:  2011-09-21

4.  Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures.

Authors:  Thiruvarangan Ramaraj; Thomas Angel; Edward A Dratz; Algirdas J Jesaitis; Brendan Mumey
Journal:  Biochim Biophys Acta       Date:  2012-01-10

5.  Blind prediction performance of RosettaAntibody 3.0: grafting, relaxation, kinematic loop modeling, and full CDR optimization.

Authors:  Brian D Weitzner; Daisuke Kuroda; Nicholas Marze; Jianqing Xu; Jeffrey J Gray
Journal:  Proteins       Date:  2014-03-31

Review 6.  Computer-aided antibody design.

Authors:  Daisuke Kuroda; Hiroki Shirai; Matthew P Jacobson; Haruki Nakamura
Journal:  Protein Eng Des Sel       Date:  2012-06-02       Impact factor: 1.650

7.  The association of heavy and light chain variable domains in antibodies: implications for antigen specificity.

Authors:  Anna Chailyan; Paolo Marcatili; Anna Tramontano
Journal:  FEBS J       Date:  2011-06-28       Impact factor: 5.542

8.  Marketed therapeutic antibodies compendium.

Authors:  Janice M Reichert
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

9.  CD-HIT: accelerated for clustering the next-generation sequencing data.

Authors:  Limin Fu; Beifang Niu; Zhengwei Zhu; Sitao Wu; Weizhong Li
Journal:  Bioinformatics       Date:  2012-10-11       Impact factor: 6.937

10.  SAbDab: the structural antibody database.

Authors:  James Dunbar; Konrad Krawczyk; Jinwoo Leem; Terry Baker; Angelika Fuchs; Guy Georges; Jiye Shi; Charlotte M Deane
Journal:  Nucleic Acids Res       Date:  2013-11-08       Impact factor: 16.971

View more
  11 in total

Review 1.  How repertoire data are changing antibody science.

Authors:  Claire Marks; Charlotte M Deane
Journal:  J Biol Chem       Date:  2020-05-14       Impact factor: 5.157

2.  ABodyBuilder: Automated antibody structure prediction with data-driven accuracy estimation.

Authors:  Jinwoo Leem; James Dunbar; Guy Georges; Jiye Shi; Charlotte M Deane
Journal:  MAbs       Date:  2016-07-08       Impact factor: 5.857

3.  DynaDom: structure-based prediction of T cell receptor inter-domain and T cell receptor-peptide-MHC (class I) association angles.

Authors:  Thomas Hoffmann; Antoine Marion; Iris Antes
Journal:  BMC Struct Biol       Date:  2017-02-02

4.  Inhibitory Monoclonal Antibodies and Their Recombinant Derivatives Targeting Surface-Exposed Carbonic Anhydrase XII on Cancer Cells.

Authors:  Dovile Stravinskiene; Aiste Sliziene; Lina Baranauskiene; Vilma Petrikaite; Aurelija Zvirbliene
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 5.  VHH Structural Modelling Approaches: A Critical Review.

Authors:  Poonam Vishwakarma; Akhila Melarkode Vattekatte; Nicolas Shinada; Julien Diharce; Carla Martins; Frédéric Cadet; Fabrice Gardebien; Catherine Etchebest; Aravindan Arun Nadaradjane; Alexandre G de Brevern
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

6.  Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration.

Authors:  Arthur J Van De Vyver; Antje-Christine Walz; Mariette S Heins; Afsaneh Abdolzade-Bavil; Thomas E Kraft; Inja Waldhauer; Michael B Otteneder
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

7.  Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy.

Authors:  Frieder Bauss; Martin Lechmann; Ben-Fillippo Krippendorff; Roland Staack; Frank Herting; Matthias Festag; Sabine Imhof-Jung; Friederike Hesse; Marc Pompiati; Gwendlyn Kollmorgen; Rita da Silva Mateus Seidl; Birgit Bossenmaier; Wilma Lau; Christian Schantz; Jan O Stracke; Ulrich Brinkmann; Masanori Onda; Ira Pastan; Klaus Bosslet; Gerhard Niederfellner
Journal:  Mol Oncol       Date:  2016-07-14       Impact factor: 7.449

8.  Bioluminescent Antibodies for Point-of-Care Diagnostics.

Authors:  Lin Xue; Qiuliyang Yu; Rudolf Griss; Alberto Schena; Kai Johnsson
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-16       Impact factor: 15.336

9.  Back-to-Germline (B2G) Procedure for Antibody Devolution.

Authors:  Anja Schrade; Alexander Bujotzek; Christian Spick; Martina Wagner; Johannes Goerl; Xenia Wezler; Guy Georges; Roland E Kontermann; Ulrich Brinkmann
Journal:  Antibodies (Basel)       Date:  2019-08-26

10.  Computational approaches to therapeutic antibody design: established methods and emerging trends.

Authors:  Richard A Norman; Francesco Ambrosetti; Alexandre M J J Bonvin; Lucy J Colwell; Sebastian Kelm; Sandeep Kumar; Konrad Krawczyk
Journal:  Brief Bioinform       Date:  2020-09-25       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.